1. Ou, W. et al. Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma. Free Radic Biol Med 112, 597-607 (2017).

2. Mulik, R.S. et al. Elucidating the structural organization of a novel low-density lipoprotein nanoparticle reconstituted with docosahexaenoic acid. Chem Phys Lipids 204, 65-75 (2017).

3. Wen, X. et al. Hepatic Arterial Infusion of Low-Density Lipoprotein Docosahexaenoic Acid Nanoparticles Selectively Disrupts Redox Balance in Hepatoma Cells and Reduces Growth of Orthotopic Liver Tumors in Rats. Gastroenterology 150, 488-498 (2016).

4. Satapati, S. et al. Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver. J Clin Invest 126, 1605 (2016).

5. Mulik, R.S. et al. Localized delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat brain using focused ultrasound. Biomaterials 83, 257-268 (2016).

6. Moss, L.R., Mulik, R.S., Van Treuren, T., Kim, S.Y. & Corbin, I.R. Investigation into the distinct subcellular effects of docosahexaenoic acid loaded low-density lipoprotein nanoparticles in normal and malignant murine liver cells. Biochim Biophys Acta 1860, 2363-2376 (2016).

7. Reynolds, L., Mulik, R.S., Wen, X., Dilip, A. & Corbin, I.R. Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells. Nanomedicine (Lond) 9, 2123-2141 (2014).

8. Corbin, I.R., Ng, K.K., Ding, L., Jurisicova, A. & Zheng, G. Near-infrared fluorescent imaging of metastatic ovarian cancer using folate receptor-targeted high-density lipoprotein nanocarriers. Nanomedicine (Lond) 8, 875-890 (2013).

9. Corbin, I.R. Ligand-coupled lipoprotein for ovarian cancer-specific drug delivery. Methods Mol Biol 1049, 467-480 (2013).

10. McKee, T.D., Chen, J., Corbin, I., Zheng, G. & Khokha, R. Quantifying Nanoparticle Transport in Vivo Using Hyperspectral Imaging with a Dorsal Skinfold Window Chamber. J Innov Opt Health Sci 5 (2012).

11. Marotta, D.E. et al. Evaluation of bacteriochlorophyll-reconstituted low-density lipoprotein nanoparticles for photodynamic therapy efficacy in vivo. Nanomedicine (Lond) 6, 475-487 (2011).

12. Zhang, Z. et al. HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting. Small 6, 430-437 (2010).

13. Hill, M.L. et al. In vitro assessment of poly-iodinated triglyceride reconstituted low-density lipoprotein: initial steps toward CT molecular imaging. Acad Radiol 17, 1359-1365 (2010).

14. Zhang, Z. et al. Biomimetic nanocarrier for direct cytosolic drug delivery. Angew Chem Int Ed Engl 48, 9171-9175 (2009).

15. Glickson, J.D. et al. Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents. Adv Exp Med Biol 645, 227-239 (2009).

16. Corbin, I.R., Furth, E.E., Pickup, S., Siegelman, E.S. & Delikatny, E.J. In vivo assessment of hepatic triglycerides in murine non-alcoholic fatty liver disease using magnetic resonance spectroscopy. Biochim Biophys Acta 1791, 757-763 (2009).

17. Cao, W. et al. Synthesis and evaluation of a stable bacteriochlorophyll-analog and its incorporation into high-density lipoprotein nanoparticles for tumor imaging. Bioconjug Chem 20, 2023-2031 (2009).

18. Glickson, J.D. et al. Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents. Mol Imaging 7, 101-110 (2008).

19. Watt, K., Kives, K., Corbin, I., Zhang, M. & Minuk, G.Y. Lack of susceptibility to ischemic necrosis of the remnant liver following partial hepatectomy in the rat. Hepatogastroenterology 54, 463-465 (2007).

20. Song, L. et al. Naphthalocyanine-reconstituted LDL nanoparticles for in vivo cancer imaging and treatment. Int J Nanomedicine 2, 767-774 (2007).

21. Corbin, I.R. & Zheng, G. Mimicking nature's nanocarrier: synthetic low-density lipoprotein-like nanoparticles for cancer-drug delivery. Nanomedicine (Lond) 2, 375-380 (2007).

22. Chen, J. et al. Ligand conjugated low-density lipoprotein nanoparticles for enhanced optical cancer imaging in vivo. J Am Chem Soc 129, 5798-5799 (2007).

23. Zhang, M., Gong, Y., Corbin, I. & Minuk, G.Y. The effects of light and moderate-heavy ethanol exposure on the development of cirrhosis in rats. Dig Dis Sci 51, 1732-1737 (2006).

24. Corbin, I.R. et al. Low-density lipoprotein nanoparticles as magnetic resonance imaging contrast agents. Neoplasia 8, 488-498 (2006).

25. Li, H. et al. MR and fluorescent imaging of low-density lipoprotein receptors. Acad Radiol 11, 1251-1259 (2004).

26. Corbin, I.R., Ryner, L.N., Singh, H. & Minuk, G.Y. Quantitative hepatic phosphorus-31 magnetic resonance spectroscopy in compensated and decompensated cirrhosis. Am J Physiol Gastrointest Liver Physiol 287, G379-384 (2004).

27. Zhang, M., Uhanova, J., Corbin, I., Bernstein, C. & Minuk, G.Y. Effects of daily, light and moderate-heavy ethanol exposure on extent of hepatic injury and recovery following toxin-induced acute hepatitis in rats. Dig Dis Sci 48, 926-931 (2003).

28. Corbin, I.R. & Minuk, G.Y. Serial percutaneous liver biopsies in laboratory rats. Dig Dis Sci 48, 1939-1943 (2003).

29. Corbin, I.R. et al. Hepatic 31P MRS in rat models of chronic liver disease: assessing the extent and progression of disease. Gut 52, 1046-1053 (2003).

30. Corbin, I.R. et al. Utility of hepatic phosphorus-31 magnetic resonance spectroscopy in a rat model of acute liver failure. J Investig Med 51, 42-49 (2003).

31. Corbin, I.R., Gong, Y., Zhang, M. & Minuk, G.Y. Proliferative and nutritional dependent regulation of glyceraldehyde-3-phosphate dehydrogenase expression in the rat liver. Cell Prolif 35, 173-182 (2002).

32. Corbin, I.R. et al. Regenerative activity and liver function following partial hepatectomy in the rat using (31)P-MR spectroscopy. Hepatology 36, 345-353 (2002).

33. Zhang, M. et al. Light ethanol consumption enhances liver regeneration after partial hepatectomy in rats. Gastroenterology 119, 1333-1339 (2000).

34. Corbin, I., Novak, M. & Blackburn, B.J. Changes in hepatic lipids of mice infected with cysticerci of Taenia crassiceps. J Helminthol 74, 209-214 (2000).

35. Corbin, I., Simcoff, R., Novak, M. & Blackburn, B.J. Metabolism of [3-(13)C]-pyruvate by cysticerci of Taenia crassiceps. Parasitol Res 84, 516-518 (1998).

36. Corbin, I., Blackburn, B.J., Wolowiec, T. & Novak, M. Metabolic profile of the liver of mice infected with cysticerci of Taenia crassiceps. Parasitol Res 82, 273-275 (1996).